ABMD

Abiomed Inc

Biotechnology

The Incredible Technology Saving Critically Ill COVID-19 Patients

by

One of the starkest lessons of the global novel coronavirus pandemic is the need for medicine to start looking at existing drugs and procedures in a new way.

We've already seen the benefits of such an approach. The discovery that remdesivir and dexamethasone – an antiviral and a steroid – could both help save severely ill COVID-19 patients' lives springs right to mind.

But adapting the old to fight the new isn't just limited to drugs. Existing medical technology ("medtech") is being used in entirely new ways, or in situations that would've been unthinkable just 10 or 12 months ago.

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died… Full Story

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died...

Stocks

This Healthcare Stock to Buy Is Set to Absolutely Skyrocket

by

The best healthcare stock to buy now is a company that makes life-saving products.

But it also expects earnings to rise more than 100% over the next three years.

This company serves over 100 million people around the world suffering from heart disease annually.

Many of them don't meet the criteria for coronary bypass surgery or transplants due to the high risk.

But that's what puts this company's technology so high in demand.

Read more here...

Biotechnology

These 5 Indicators Tell Me This Stock Will Double by 2020

by

Jara Herron, the owner of a salon and day spa in Tulsa, Okla., had just given birth to her seventh child about six years ago when she suddenly felt her chest getting tighter.

When she got to the hospital, Herron learned she was having a heart attack. Her organs soon began to fail, so doctors put her into a medical coma.

Because Herron was not a candidate for a heart transplant, her doctors instead turned to the world's smallest heart pump, one that can be inserted with a noninvasive catheter. That heart pump saved Herron's life.

And it's done the same thing for thousands of other patients around the United States.

But that's far from the only thing this innovative heart pump has done.

It's also helped hand investors 569% gains.

Its maker is a cutting-edge medtech firm with deep expertise with heart patients.

Those big gains are just a start for this life sciences leader.

In fact, it's set to double your money in as little as two years...